Verition Fund Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Verition Fund Management's PFE Position: Q1 2026 in Review
Verition Fund Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 248,837 shares — an estimated $6.62M sold.
Verition Fund Management first reported a position in PFE in Q3 2013 and held it in 37 quarters. The position peaked at $9.32M in Q3 2025. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Verition Fund Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
- Verition Fund Management sold 248,837 Pfizer shares in Q1 2026, an estimated $6.62M.
- Verition Fund Management first reported a position in Pfizer in Q3 2013 and held it in 37 quarters.
- Verition Fund Management's Pfizer position peaked at $9.32M in Q3 2025.
- 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.